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Abstract
Background: Odontogenic tumors (OTs) are rare lesions, exclusive of the jaws, that are derived from epithelial 
and/or ectomesenchymal elements of the tooth-forming apparatus. Their biological behavior is heterogeneous, 
including hamartomatous tissue proliferation, benign nonaggressive and aggressive neoplasms, and malignant 
tumors with metastatic capacity. The aim of this study was to describe the relative frequency of odontogenic tu-
mors in a Brazilian population. In addition, a review of the literature identified studies on odontogenic tumors that 
follow the 2005 World Health Organization.
Material and Methods: A total of 376 cases of odontogenic tumors from an oral pathology service were reviewed 
about age, gender, anatomic site and histologic diagnosis. 
Results: Keratocystic odontogenic tumors (31.6%) were the most common, followed by ameloblastoma (28.5%), 
and odontoma (22.6%). The mean age was 32.2 years, and more than half the patients (52.1%) were in the second 
and third decades of life. The male to female ratio was 1:1.37, with a maxilla to mandible ratio of 1:2.08.
Conclusions: The variation in relative frequency of tumors observed among the several series, including the 
present study, is probably due in part to cultural differences between geographic areas but also to the study de-
sign.
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Introduction
Odontogenic tumors (OTs) are rare lesions, exclusive 
of the jaws, that are derived from epithelial and/or ec-
tomesenchymal elements of the tooth-forming appara-
tus. Their biological behavior is heterogeneous, includ-
ing hamartomatous tissue proliferation, benign nonag-
gressive and aggressive neoplasms, and malignant tu-
mors with metastatic capacity (1).
Since 2005, epidemiological OT studies have followed 
two major classificatory systems. The majority of these 
studies are based on the 2005 WHO classification of tu-
mors (1-13). On the other hand, other studies still fol-
lowed the 1992 WHO classification (14-19). The changes 
in the 2005 classification included terminology, classifi-
cation as benign or malignant or assignment to relevant 
subgroups, in particular the benign tumors (20). How-
ever, the main difference for relative frequencies stud-
ies was the addition of the odontogenic keratocyst to the 
benign OTs, termed as keratocystic odontogenic tumor 
(KCOT). This redefinition produced a huge increase 
in the frequency and prevalence of OTs (12), without, 
however, impacts on the treatment conventions for the 
KCOTs (20).
Knowledge of prevalence of the OTs can be extremely 
valuable both for pathologists and clinicians when de-
veloping differential diagnosis (4). Reports on the rela-
tive frequency of OTs from different countries show a 
distinct geographic variation (6,8,12,13). Although some 
reports have been published concerning the relative fre-
quency of OTs in Brazil (3,8,10,12,21,22), few studies 
are based on large samples from a single institution 
(12,22). Thus, the objective of this study is to describe 
the relative frequency of OTs at the Oral Pathology 
Laboratory at the University of Fortaleza (Ceará State, 
Brazil) over a period of 12 years, based on the 2005 
WHO classification (1). We then compare these results 
with previous studies published from other parts of the 
world, including one previous study from the same state 
of Ceará in Brazil.
 
Material and Methods 
This cross-sectional study was approved by the insti-
tutional Ethics Commitee  (ethics approval number 
1104619). A total of 9100 biopsy records were reviewed 
and 376 (4.1%) met the inclusion criteria for 2005 WHO 
classification for OTs (1). Recurrent tumors as well as 
cases with repeated biopsies of the same lesion were 
excluded. 
Within this laboratory, all diagnosis requires the 
consensus of two pathologists. The data collected 
from the clinical records and histopathological report 
included a unique biopsy number, patient age at the date 
of the biopsy, gender, tumor site and histopathological 
diagnosis. Personal or identifiable information was not 
recorded to maintain anonymity. 
Age at the time of the diagnosis was treated as a con-
tinuous variable, but also categorized into eight age 
groups, with a 10-year interval. All tumor sites were 
classified into anterior maxilla, posterior maxilla, an-
terior mandible, or posterior mandible. The histopatho-
logical diagnoses were adapted to the 2005 WHO clas-
sification of OTs (1). The resulting data set was analyzed 
using the Statistical Package for Social Science, version 
20.0 (SPSS, Chicago, IL).
Comparison studies were identified from the existing 
literature (PubMed Database) of series of odontogenic 
tumors published between 2005 and 2015. These stud-
ies all used the 2005 WHO classification (1), and those 
that did not mention the malignant tumors or failed to 
include any of the most prevalent benign tumors were 
excluded. 
Results
In the data set, 99.2% of the tumors were benign and 
0.8% were malignant. Primary intraosseous squamous 
cell carcinoma (PIOSCC) (0.5%) and ameloblastic car-
cinoma (AC) (0.3%) were the only two malignant en-
tities. Keratocyst odontogenic tumor (KCOT) was the 
most frequent benign tumor (31.6%) followed by amel-
oblastoma (28.5%), odontoma (22.6%), and odontogenic 
myxoma (4.5%). Other benign OTs comprised between 
0.3% and 4.3%. Regarding tumor histogenesis, 65.9% 
of the tumors were classified as OTs of odontogenic epi-
thelium with mature fibrous stroma without odontogen-
ic ectomesenchyme; 27.9% were OTs of odontogenic 
epithelium with odontogenic ectomesenchyme, with or 
without hard tissue formation; and 6.1% were OTs of 
mesenchyme and/or odontogenic ectomesenchyme with 
or without odontogenic epithelium. 
Table 1 shows the relative frequency and gender distri-
bution of OTs. In three biopsies (0.8%), the gender of 
the patient was not provided and thus not included in the 
results. There were 157 (41.8%) male specimens and 216 
(57.4%) female specimens, for a gender ratio of 1:1.37. 
For the three most frequently observed tumors (KCOT, 
ameloblastoma, and odontomas), the male:female ratios 
are 1:1.05, 1:1.3, and 1:1.89) respectively.
As shown in table 2, the age of patients at diagnosis 
ranged from 3 to 99 years with a mean of 32.2(±18.7) 
years. The peak age categories of occurrence are in the 
second and third decades of life, which comprised more 
than half the diagnosed OTs biopsies (52.1%). Overall, 
the KCOT and ameloblastoma show the higher relative 
frequencies in all decades except the first and second, 
where odontoma occurred with greater frequency. The 
third decade is the only one where the ameloblastoma is 
more common than the KCOT. 
Table 3 shows the site distribution of each type of OT, 
where 248 (65.9%) tumors were located in the mandible 
and 119 (31.70%) tumors in maxilla, for an overall max-
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Total
Gender
Abbreviation Male Female NA Ratio
n(%) n(%) n(%) n(%) M:F
AME Ameloblastoma 107(28.5) 46(12.2) 60(16.0) 1(0.2) 1:1.3
CEOT
Calcifying epithelial odonto-
genic tumor
5(1.3) 3(0.8) 2(0.5) - 1.5:1
AOT
Adenomatoid odontogenic 
tumor
14(3.7) 3(0.8) 11(2.9) - 1:3.6
KCOT Keratocyst odontogenic tumor 119(31.6) 58(15.5) 61(16.3) - 1:1.05
AF
Ameloblastic fibroma/fibro-
dentinoma
3(0.8) 1(0.2) 2(0.5) - 1:2
AFO Ameloblastic fibroodontoma 1(0.3) 1(0.2) - - -
OC Odontoma 85(22.6) 29(7.7) 55(14.7) 1(0.2) 1:1.89
CCOT
Calcifying cystic odontogenic 
tumor
16(4.3) 7(1.8) 8(2.1) 1(0.2) 1:1.1
OF Odontogenic fibroma 1(0.3) - 1(0.2) - -
OM
Odontogenic myxoma/fi-
bromyxoma
17(4.5) 8(2.1) 9(2.4) - 1:1.1
CB Cementoblastoma 5(1.3) 1(0.2) 4(1.0) - 1:4
AC Ameloblastic carcinoma 1(0.3) - 1(0.2) - -
PIOSCC
Primary intraosseous squa-
mous cell carcinoma
2(0.5) - 2(0.5) - -
Total  376(100) 157(41.8) 216(57.4) 3(0.8) 1:1.37
Table 1. Gender distribution of odontogenic tumors.
NA, not available.
Note: the percentages here are for the total number of tumors. 
  
Group Age Age 
0-9 10-19 20-29 30-39 40-49 50-59 60-69 >70 
Mean±SD Range 
 
n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) 
AME - 21(20.6) 31(30.4) 12(11.4) 13(12.7) 7(6.9) 9(8.8) 9(8.8) 36.3±19.6 10-83 
CEOT - - 1(25.0) 1(25.0) 2(50.0) - - - 36.0±10.0 25-45 
AOT - 5(38.5) 5(38.5) 1(7.7) 2(15.4) - - - 24.3±10.5 25-45 
KCOT - 22(19.8) 28(25.2) 14(12.6) 20(18.0) 12(10.8) 10(9.0) 5(4.5) 36.6±18.2 11-96 
AF 1(33.3) 2(66.7) - - - - - - 11.3±2.5 9-14 
AFO 1(100) - - - - - - - 3.0  3 
OC 12(14.5) 35(43.8) 17(21.2) 10(12.5) 4(5.0) 1(1.2) 1(1.2) - 20.1±11.8 4-62 
CCOT - 4(28.6) 4(28.6) 1(7.1) 2(14.3) 1(7.1) - 2(14.2) 37.5±25.8 14-99 
OF - - - - - 1(100.0) - - 54.0 54 
OM - 2(13.3) 5(33.3) 3(20.0) 5(33.3) - - - 32.8±11.7 18-49 
CB - - 1(25.0) - 1(25.0) 2(50.0) - - 42.5±16.3 20-56 
AC - - - - - - 1(100.0) - 63.0 63 
PIOSCC - - - - 1(50.0) - - 1(50.0) - - 
Total 14(4.0) 91(25.9) 92(26.2) 42(12.0) 50(14.2) 24(6.8) 21(6.0) 17(4.9) 32.2±18.7 3-99 
!
Table 2. Age distribution of odontogenic tumors.
NA, not available.
Note: the percentages here are for the total number of tumors. 
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illa-mandible ratio of 1:2.08. In maxilla, the anterior re-
gion was the predominant site of involvement, mostly 
contributed by odontoma. The posterior region of the 
mandible was the frequent site of involvement in 190 
(50.5%) tumors. Ameloblastoma showed a high man-
dibular predilection, whereas AOT was more common 
in the anterior region of the maxilla.
 
Discussion
This study describes a series of OTs from the Oral 
Pathology Laboratory of the University of Fortaleza, 
which is the major referral center for biopsied lesions 
in Ceará, Northeast of Brazil, a state with more than 
8.8 million inhabitants. Our sample is the largest yet 
analyzed in Brazil.  There is, however, a previous study 
from the population of Ceará conducted by Osterne et 
al. (8) albeit using a smaller sample.
Despite the fact that some studies published after 2005 
did not observe the latest WHO classification for OTs, 
(14-18) the majority of studies have employed the 2005 
classification (2-13). Servato et al. (12) showed that the 
average proportion of OTs among oral and maxillofa-
cial lesions evaluated by histopathology increased from 
3% (±2.9%) in studies that used the 1992 WHO (19) 
classification of tumors to 4.0% (±1.3%) in those with 
the later classification. This is in concordance with the 
present study, where the relative frequency of OTs is 
4.1% of the total biopsied specimens between January 
2001 and December 2013. However, there seems to be 
significant geographical variation in the frequency of 
OTs, with lower rates in Europe (15) (0.84%) and North 
America (14) (1.2%) and higher rates in Asia (18) (4.1%) 
and Africa (23) (9.3%). In Brazil, the frequency rates 
range between 1.3% and 4.76%, most likely due to in-
herent regional disparities between the Northeast and 
the Center-South (3,10,12).
Across all the studies reviewed for comparison, the 
most frequent OT is ameloblastoma (39.1%), followed 
by KCOT (32.1%), and odontoma (10.2%) (Table 4). 
These rates differ from the order of magnitude in our 
study where KCOT is more frequent (31.6%), followed 
by ameloblastoma (28.5%) and odontoma (22.6%). 
These differences in the rankings of frequencies, espe-
cially for KCOT and ameloblastoma, appear to follow a 
distinct geographical pattern. In the studies conducted 
in the Western Hemisphere (including Brazil) KCOT is 
reported with the greatest frequency, while in the Asian 
and African studies, ameloblastoma is the most frequent 
OT (2,3,5-7,9-12).
Odontoma is the third most common OT, although the 
frequencies differ meaningfully between studies.  Freg-
nani et al. (24) argue that differences in results are due 
to data sources, rather than geography. Medical hospi-
tals underestimate odontoma frequencies and overesti-
  
Maxilla Mandible 
NA Total 
Maxilla-
mandible Anterior Posterior Total Anterior Posterior Total 
 
n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) ratio 
AME 4(3.7) 3(2.8) 7(6.5) 17(15.8) 79(73.8) 96(89.7) 4(3.7) 107(100.0) 1:12.2 
CEOT 1(20.0) 1(20.0) 2(40.0) 1(20.0) 1(20.0) 2(40.0) 1(20.0) 5(100.0) 1:1 
AOT 6(42.8) 5(35.7) 11(78.5) 1(7.1) 2(14.2) 3(21.4) - 14(100.0) 3.6:1 
KCOT 12(10.1) 20(16.8) 32(26.9) 17(14.3) 69(58.0) 86(72.3) 1(0.8) 119(100.0) 1:2.63 
AF - 1(33.3) 1(33.3) - 2(66.7) 2(66.7) - 3(100.0) 1:2 
AFO - - - - 1(100.0) 1(100.0) - 1(100.0) - 
OC 33(38.8) 15(17.6) 48(56.4) 16(18.8) 20(23.5) 36(42.3) 1 85(100.0) 1.2:1 
CCOT 5(31.2) 4(25.0) 9(56.2) 3(18.7) 3(18.7) 6(37.5) 1(6.25) 16(100.0) 1.5:1 
OF - - - - 1(100.0) 1(100.0) - 1(100.0) - 
OM 1(5.8) 7(41.1) 8(47.0) 2(11.7) 6(35.2) 8(47.0) 1(5.8) 17(100.0) 1:1 
CB 1(20) - 1(20) - 4(80) 4(80) - 5(10.00) 1:4 
AC - - - - 1 1(100.0) - 1(100.0) - 
PIOSCC - - - 1(50.0) 1(50.0) 1(50.0) - 2(100.0) - 
Total 63(16.8) 56(14.9) 119(31.7) 58(15.4) 190(50.5) 248(65.9) 9(2.3) 376(100)  1:2.08 
!
Table 3. Site distribution of odontogenic tumors.
NA, not available.
Note: the percentages here are for the total number of tumors. 
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mate the rates of tumors that require extensive surgical 
procedures. Moreover, in several developing countries, 
odontomas are occasionally not registered or sent for 
histological confirmation. In the current study, the rela-
tive frequency for odontomas was 22.6% and this is in 
concordance with Brazilian series conducted by Avelar 
et al. (3) (22.1%), Costa et al. (10) (18.4%), and Osterne 
et al. (8) (19.4%). 
In general, the comparison of studies found wide varia-
tions in the occurrence of the less frequent tumors, such 
as odontogenic myxoma (2.2% - 6.3%), AOT (0.5% - 
5.8%), and cementoblastoma (0% - 3.7%).  Despite some 
divergence, our results are consistent with the averages 
of the other studies reviewed here (4.5% vs 4.0% re-
spectively for odontogenic myxoma; 3.7% vs 3.5% for 
AOT; and 1.3% vs 1.3% for cementoblastoma). It should 
be mentioned that our relative frequency for calcifying 
cystic odontogenic tumor (4.3%) were slightly higher 
compared to other studies (2.2%), however, these differ-
ences are confirmed in other Brazilian studies-Osterne 
et al. (8), Servato et al. (12), and Avelar et al. (3), with 
rates of 3.7%, 3.8% and 6.3%, respectively. Also, the 
low occurrence of calcifying epithelial odontogenic tu-
mor (1.3%), ameloblastic fibroma (0.8%), ameloblastic 
fibro-odontoma (0,3%), and odontogenic fibroma (0.3%) 
was comparable to findings reported elsewhere (7,11).
Malignant OTs in the present study represented 0.8% of 
the total OTs. This relative frequency is similar to other 
reports from the Western Hemisphere countries that 
ranged from 0% to 1.1% (25-27), but contrast with the 
significantly higher rates from Africa (23) and China 
(4), 5.8% to 5.9% respectively.
Regarding gender, the literature states that male patients 
are more affected by OTs than females (Table 5). How-
ever, it seems that the gender distribution of OTs also 
shows a geographic variation, as reported in studies 
from South America (3,5,8,12,27), including the present 
study, where higher female rates were identified. 
Comparison rates across studies suggest that frequency 
rates do not vary in terms of average age, but there are 
strong geographic differences with regard to the age 
decade in which the different OTs occur. The Brazil-
ian studies show that the second decade of life is the 
most affected (3,8,12), followed by the third decade. 
In Egypt, India and Sri-Lanka, on the other hand, the 
order of age decades is reversed and the third decade 
Jing  
et al. (2) 
Avelar  
et al. (3) 
Luo and  
Li (4)  
Gaitán-
Cepeda (5) 
Tawfik 
and 
Zyada (6) 
Gill  
et al. (7) 
Osterne 
et al. (8) 
Varkhee 
et al. (9) 
Costa  
et al. (10) 
Siriwardena 
et al. (11) 
Servato  
et al. (12) 
Sekerci  
et al. (13) Total Present Study 
2007 2008 2009 2010 2010 2011 2011 2011 2012 2012 2013 2015 
n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) 
AME 661(40.3) 57(23.7) 478(36.5) 25(18.3) 34(41.5) 99(47.4) 54(29.1) 49(40.8) 60(29.8) 
816(48.
6) 
48(20.0) 66(29.8) 2447(39.1) 107(28.5) 
SOT (0.2) 1(0.4) 0 0 0 0 0 1(0.8) 0 7(0.4) 0 0 12(0.1) 0 
CEOT 10(0.6) 5(2.0) 6(0.4) 2(1.4) 3(3.7) 3(1.4) 1(0.5) 1(0.8) 4(2.0) 25(1,4) 2(0.8) 24(11.0) 86(1.3) 5(1.3) 
AOT 68(4.1) 13(5.4) 27(2.0) 2(1.4) 3(3.7) 16(2.8) 1(0.5) 7(5.8) 2(1.0) 78(4.6) 3(1.3) 4(1.8) 224(3.5) 14(3.7) 
KCOT 588(35.8) 69(30.0) 507(38.7) 53(38.9) 16(19.5) 49(23.4) 52(28.1) (37.5) 65(32.3) 431(25) 76(31.7) 57(26.1) 2008(32.1) 119(31.6) 
AF 19(1.2) 4(1.7) 13(0.9) 0 2(2.4) 2(1.0) 4(2.1) 1(0.8) 4(2.0) 15(0.8) 0 2(0.9) 66(1.0) 3(0.8) 
AFO 4(0.2) 1(0.4) 12(0.9) 0 0 0 0 0 2(1.0) 9(0.5) 0 1(0.4) 29(0.4) 1(0.3) 
OC 78(4.7) 54(22.1) 80(6.1) 42(30.8) 11(13.4) 11(5.3) 36(19.4) 14(11.6) 37(18.4) 
169(10.
0) 
76(31.6) 35(16.0) 643(10.2) 85(22.6) 
OA 2(0.1) 0 0 0 0 0 0 0 0 0 0 0 2(0.03) 0 
CCOT 36(2.2) 15(6.3) 26(1.9) 0 0 16(7.5) 7(3.7) 1(0.8) 4(2.0) 24(1.4) 9(3.8) 3(1.3) 141(2.2) 16(4.3) 
DGCT 9(0.5) 0 5(0.3) 0 0 0 0 0 1(0.5) 5(0.2) 1(0.4) 2(0.9) 23(0.3) 0 
OF 5(0.3) 0 21(1.6) 2(1.4) 0 0 7(3.7) 0 0 7(0.4) 5(2.1) 4(1.8) 51(0.8) 1(0.3) 
OM 76(4.6) 15(6.3) 34(2.6) 8(5.8) 7(8.5) 7(3.3) 13(7.0) 0 9(4.5) 67(3.9) 11(4.6) 5(2.2) 252(4.0) 17(4.5) 
CB 33(2.0) 4(1.7) 22(1.6) 0 3(3.7) 6(2.9) 7(3.7) 1(0.8) 2(1.0) 1(0.05) 4(1.7) 2(0.9) 85(1.3) 5(1.3) 
AC 27(1.6) 0 17(1.3) 0 0 0 0 0 7(3.5) 3(0.1) 3(1.3) 1(0.4) 58(0.9) 1(0.3) 
MAME 0 0 0 0 1(1.2) 0 0 0 0 1(0.05) 0 0 2(0.03) 0 
PIOSCC 14(0.9) 0 49(3.7) 0 2(2.4) 0 0 0 1(0.5) 13(0.7) 1(0.4) 10(4.5) 87(1.3) 2(0.5) 
CCOC 2(0.1) 0 8(0.6) 0 0 0 0 0 1(0.5) 5(0.2) 1(0.4) 2(0.9 19(0.3) 0 
GCOC 5(0.3) 0 3(0.2) 0 0 0 0 0 0 0 0 0 8(0.1) 0 
AFS 2(0.1) 0 1(0.08) 0 0 0 0 0 2(1.0) 1(0.05) 0 0 6(0.1) 0 
NSOT 0 0 0 0 0 0 3(1.6) 0 0 0 0 0 6(0.1) 0 
Total 1642(100) 238(100) 1309(100) 136(100) 82(100) 209(100) 185(100) 120(100) 201(100) 1677(100) 240(100) 218(100) 6255(100) 376(100) 
!
Table 4. Distribution of odontogenic tumors by diagnosis.
NA, not available.
Note: the percentages here are for the total number of tumors.
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shows the highest rates (6,9,11). In the present study, the 
second and the third decades of life were the most com-
mon and equally affected. In China and Turkey (2,4,13), 
the third and fourth decades were most afflicted. These 
variations clearly mirror the percentages of KCOT, 
ameloblastoma and odontoma in each study. Because 
odontoma occurs in younger patients, in studies where 
the relative frequency of this tumor is high, the second 
and third decade of life are the most affected (3,8,9,12). 
Where high frequencies of ameloblastoma are present, 
the age occurrence shifts to the third and fourth decades 
(2,4,13). In contrast, KCOT is distributed more uniform-
ly across age. 
Specifically with regard to ameloblastoma, the mean 
age of occurrence does show significant variation 
across countries.  Reichart et al. (28) report a mean age 
in developing countries to be 27.7 years and in devel-
oped countries to be 39.1 years. In the current study, the 
mean age of occurrence for ameloblastoma (36.6 years) 
was closer to that reported by Reichart et al. (28) for 
developed countries, showing that there might be oth-
ers factors involved. It has been previously show by 
Ledesma-Montes et al. (29), in a study of 163 amelobas-
toma cases from Latin-America, that solid ameloblas-
toma has a higher mean age of occurrence (41.4 years) 
than unicystic ameloblastoma (26.3 years), in fact, not 
a single case of solid ameloblastoma was found in pa-
tient younger than 20-years old in their series. In the 
present study, information about the subtypes of amel-
oblastomas included is not available, and this may by a 
limitation factor for explaining the possible differences 
between the mean age of this and other series. Other 
studies of ameloblastoma from different regions, with 
homogeneous and actually accepted criteria to differen-
tiate unicystic ameloblastoma and solid ameloblastoma 
could help to clarify if there are geographics or ethnics 
differences in occurrence of ameloblastomas.
Odontoma is frequently found in the first and second 
decade of life with the mean age of 18.4 years (14). The 
slightly higher mean age (20.1 years) seen in the present 
study for odontomas probably reveals the fact that Bra-
zilian patients do not frequently undergo routine pan-
oramic X-ray and so odontomas are not diagnosed as 
early. A systematic review of KCOT revealed a mean 
age of 36.5 years with a peak of incidence in the second 
and third decades of life (30). Our mean age were simi-
lar (36.6 years), but with a smoother distribution over 
the decades.  The other OT that shows a marked pat-
tern by an age group is AOT (31), where 65% of these 
tumors occur in the second decade of life. In our data, 
77% of AOTs were equally distributed between the sec-
ond and the third decades of life. That delay in the age 
of diagnosis was probably due to the fact that, likewise 
odontomas, AOT exhibits self-limiting growth and does 
not require urgent treatment.
Most OTs were found in the posterior region of the man-
dible. The current study presented a maxilla:mandible 
ratio of 1:2.08. A higher maxilla:mandible ratio (1:3.6) 
were reported in literature (8) which reflects the rela-
tively higher rates of ameloblastomas in large samples 
(2,4,11). Ameloblastomas, KCOT and cementoblasto-
mas are widely known to affect more the posterior re-
gion of mandible (1,8,14). In accordance with literature, 
our study shows that 73.8% of the ameloblastomas and 
!
  Gender Mean Site 
 
Total Male Female Ratio Age Total Maxilla Mandible Ratio 
 
n n n M:F years n n n Max:Mand 
Jing et al. (2) 1639 959 680 1.41:1.00 32.1 1615 322 1293 1:4.01 
Avelar et al. (3) 238 102 136 1.00:1.33 NA 238 78 160 1:2.05 
Luo and Li (4) 1309 751 558 1.35:1.00 34.4 1264 281 983 1:3.49 
Gaitán-Cepeda (5) 136 83 53 1.56:1:00 NA NA NA NA NA 
Tawfik and Zyda (6) 82 44 38 1.20:1.00 29.5 82 14 68 1:4.85 
Osterne et al. (8) 185 71 114 1.00:1.60 30.5 165 52 113 1:2.10 
Deepthi et al. (7) 305 166 139 1.19:1.00 33.7 302 72 230 1:3.19 
Varkhede et al. (9) 120 70 50 1.40:1.00 NA 120 32 88 1:2.75 
Costa et al. (10) 201 115 86 1.33:1.00 35.0 192 52 140 1:2.69 
Siriwardena et al. (11)  1677 858 819 1.00:1.04 30.8 1424 371 1053 1:2.83 
Servato et al. (12) NA NA NA 1.00:1.10 29.0 227 64 163 1:2.54 
Sekerci et al. (13) 218 110 108 1.01:1.00 34.5 218 48 170 1:3.54 
Present Study 373 157 216 1.00:1.37 32.2 367 119 248 1:2.08 
Table 5. Gender, mean age, and site distribution of odontogenic tumors.
NA, not available.
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57.9% KCOTs occur in that region. Cementoblastomas, 
also showed a strong mandible occurrence (80%), de-
spite their relative scarcity in the sample as a whole.  In 
contrast, AOT and odontomas occur more frequently 
in the maxilla, accounting for 78.5% and 56.4% of the 
sites, respectively. These observations are confirmed by 
Gupta & Ponniah et al. (18), Avelar et al. (3), Deepthi et 
al. (7), but not by Buchner et al. (14) and Jing et al. (2).
While most studies show the predominant occurrence 
of odontogenic myxomas in the mandible (8), our results 
reveal an equal distribution of odontogenic myxoma be-
tween maxilla (47.0%) and mandible (47.0%). No con-
clusions could be drawn with regard to gender, age and 
anatomic site predilection for the rarest OTs (CEOT, AF, 
OF, CB, AC, and PIOSCC) owing to paucity of cases. 
It was interesting to see that our results are in accord-
ance with a previous study conducted by Osterne et al. 
(8) in the same region – state of Ceará/Brazil - with data 
from 2001 to 2005. The relative frequencies of the most 
common tumors were similar, and the maxila:mandible 
ratio was almost identical (1:2.08 vs 1:2.1). In both stud-
ies, the second and the third decades of life were the most 
affected, which taken together accounted for 52.1% and 
51.27% of the total number of tumors between our study 
and that of Osterne et al. (8). The gender distribution 
showed the larger difference with a male:female ratio 
of 1:1.37 for our study compared to 1:1.6 for Osterne et 
al. (8).
Lastly, it is important to highlight that although we 
serve the majority of the State of Ceará, there are some 
biopsies analyzed in other laboratories. Also, because 
the size and age of patient population are unknown, we 
cannot calculate prevalence and incidence rates.  Nev-
ertheless, this is the largest study of its kind in the coun-
try, so it provides valuable information on the types of 
tumors and percentages of each type of tumor by age, 
gender, and anatomic site. 
In conclusion, overall our results are shared by the oth-
ers Brazilian studies but show marked geographic vari-
ation to those reported from Asia and Africa. The vari-
ations in relative frequency of tumors observed among 
the several series, including the present study, are prob-
ably due in part to underlying cultural differences be-
tween geographic areas but also to differing elements of 
the study design, which would require further research 
to determine.
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